S&P 500
7,666.60
+35.13
+0.46%
Dow
53,061.95
+295.05
+0.56%
Nasdaq
26,217.83
+118.06
+0.45%
NYSE Composite
24,495.55
+146.25
+0.60%
Russell 2000
2,953.17
+33.04
+1.13%
VIX
15.33
+0.13
+0.86%
AMGN · Amgen Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
Amgen Inc (AMGN)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$442.83
+4.70
(+1.07%)
● At close: September 2 at 4:00:00 PM EDT
$442.70
-0.14
(-0.03%)
Pre-Market:
8:16:21 AM EDT
DAY'S RANGE
$442.83
$435.23
$445.36
52-WEEK RANGE
$442.83
$269.77
$447.03
What's happening
- AMGN is up 1.07% today, trading at $442.83. — Live quote
- It's trading within 3% of its 52-week high ($447.03). (Finnhub fundamentals)
- Volume today (85,483) is well below its 3-month average of 2,676,640. (Finnhub fundamentals)
- Last quarter's EPS beat estimates: $6.29 actual vs. $5.73 estimated (+9.8%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 6
Buy 14
Hold 20
Sell 2
Strong sell 1
Aggregate ratings for 2026-09-01 (43 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
AMGN
+33.85%
vs S&P 500
+22.14%
1-YEAR RETURN
AMGN
+52.70%
vs S&P 500
+33.72%
6-MONTH RETURN
AMGN
+15.50%
3-MONTH RETURN
AMGN
+33.11%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-08-04 (Q2 2026)
$6.29
Est. $5.73
BEAT +9.8%
2026-04-26 (Q1 2026)
$5.15
Est. $4.85
BEAT +6.1%
2026-01-26 (Q4 2025)
$5.29
Est. $4.83
BEAT +9.6%
2025-10-26 (Q3 2025)
$5.64
Est. $5.11
BEAT +10.3%
Valuation Measures & Ratios
Enterprise Value4$269.21B
Forward P/E516.86
PEG Ratio65.48
Price / Sales (TTM1)5.93
Price / Book716.72
EV4 / Revenue7.07
EV4 / EBITDA17.82
Profit Margin22.95%
Operating Margin30.32%
Return on Equity (ROE8)89.32%
Return on Assets (ROA9)9.48%
Avg Volume (3M)2,676,640
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $195.66B | $189.09B | $148.90B | $145.60B | $161.06B |
| P/E | 22.13 | 23.07 | 16.17 | 21.61 | 31.01 |
| Price/Sales | 5.23 | 5.33 | 4.21 | 4.26 | 4.96 |
| Price/Book | 16.74 | 20.58 | 15.48 | 19.60 | 25.95 |
| EV/Revenue | 6.39 | 6.60 | 5.48 | 5.66 | 6.45 |
| EV/EBITDA | 14.72 | 16.53 | 14.02 | — | — |
| ROE | 75.65% | 89.19% | 95.73% | 90.71% | 83.66% |
| ROA | 9.25% | 8.86% | 10.22% | 7.67% | 5.81% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E and PEG aren't shown here — both need historical analyst-consensus estimates, which no free source provides; see the current-period figures above instead.
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short12,039,849
Change from Prior Settlement-9.34%
% of Float—
Days to Cover (Short Ratio)4.34
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-08-14. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Signals describe daily price patterns—not the company’s value and not a recommendation to buy or sell. Read several together; no single indicator predicts what happens next. “Overbought” and “oversold” are conditions, not promises of a reversal.
Indicators None active
Loading chart…
Free IEX historical data only goes back to ~2021 — 5Y/Full show whatever's actually available, not a promise of that much history. Indicators are computed client-side from these same price bars; earnings markers ("E") come from Finnhub's free tier (~last 4 quarters + next upcoming) — older quarters aren't available. The move-highlight dots are a heuristic (|% change| vs rolling volatility) with a best-effort headline lookup, not a claim of causation.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 9.5% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 22.9%. Finnhub fundamentals ↗
- Trailing 52-week price return is +52.7%. Finnhub market metrics ↗
Potential concerns
- Latest SEC filing is Form 4, filed 2026-08-13; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on AMGN
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.05B | $8.62B | $9.56B | $9.18B | $8.15B | $8.50B | $8.39B | $7.45B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $3.51B | $2.67B | $2.53B | $2.66B | $1.18B | $2.05B | $1.91B | $991.0M |
| Net income | $2.38B | $1.82B | $3.22B | $1.43B | $1.73B | $2.83B | $746.0M | -$113.0M |
| EPS (diluted) | $4.37 | $3.34 | $5.93 | $2.65 | $3.20 | $5.22 | $1.38 | $-0.21 |
| EPS (basic) | $4.40 | $3.37 | $5.98 | $2.66 | $3.22 | $5.27 | $1.39 | $-0.21 |
| Operating margin | $35 | $31 | $26 | $29 | $14 | $24 | $23 | $13 |
| Net margin | $24 | $21 | $34 | $16 | $21 | $33 | $9 | -$2 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $95.64B | $92.50B | $90.59B | $90.14B | $87.90B | $89.37B | $91.84B | $90.88B |
| Stockholders' equity | $11.69B | $9.19B | $8.66B | $9.62B | $7.43B | $6.21B | $5.88B | $7.53B |
| Total current assets | $34.96B | $31.48B | $29.06B | $27.89B | $26.73B | $26.93B | $29.03B | $26.77B |
| Total current liabilities | $25.50B | $24.95B | $25.49B | $21.79B | $20.48B | $23.01B | $23.10B | $20.31B |
| Cash & equivalents | $13.99B | $12.04B | $9.13B | $9.45B | $8.03B | $8.81B | $11.97B | $9.01B |
| Accounts receivable | $10.23B | $9.14B | $9.57B | $8.49B | $8.70B | $8.13B | $6.78B | $7.32B |
| Inventory | $6.22B | $6.19B | $6.22B | $6.35B | $6.58B | $6.73B | $7.00B | $7.36B |
| Other current assets | $4.53B | $4.11B | $4.13B | $3.60B | $3.42B | $3.26B | $3.28B | $3.08B |
| Property, plant & equipment | $8.55B | $8.22B | $7.91B | $7.22B | $6.86B | $6.68B | $6.54B | $6.16B |
| Goodwill | $18.67B | $18.67B | $18.68B | $18.68B | $18.67B | $18.64B | $18.64B | $18.66B |
| Intangible assets | $20.49B | $21.38B | $22.28B | $23.14B | $24.61B | $25.72B | $27.70B | $28.92B |
| Other non-current assets | $12.98B | $12.76B | $12.66B | $13.22B | $11.02B | $11.39B | $9.93B | $10.38B |
| Accounts payable | $2.87B | $2.94B | $2.37B | $2.84B | $3.01B | $2.41B | $1.91B | $2.15B |
| Accrued liabilities | $17.19B | $16.58B | $18.52B | $16.80B | $15.02B | $17.23B | $17.64B | $14.62B |
| Short-term debt | $5.45B | $5.44B | $4.60B | $2.15B | $2.44B | $3.37B | $3.55B | $3.54B |
| Long-term debt | $51.86B | $51.89B | $50.01B | $52.43B | $53.76B | $54.01B | $56.55B | $56.85B |
| Other non-current liabilities | $2.44B | $2.37B | $2.38B | $2.22B | $2.34B | $2.21B | $2.35B | $2.20B |
| Common stock & paid-in capital | $34.08B | $34.03B | $34.02B | $33.84B | $33.68B | $33.58B | $33.53B | $33.39B |
| Retained earnings | -$22.27B | -$24.65B | -$25.11B | -$23.80B | -$25.71B | -$27.14B | -$27.59B | -$25.53B |
| Accumulated other comprehensive income (loss) | -$119.0M | -$190.0M | -$258.0M | -$422.0M | -$544.0M | -$231.0M | -$66.0M | -$336.0M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.00B | $2.19B | $1.60B | $4.68B | $2.28B | $1.39B | $4.77B | $3.57B |
| Investing cash flow | -$569.0M | -$716.0M | -$693.0M | -$414.0M | -$389.0M | -$447.0M | -$402.0M | -$210.0M |
| Financing cash flow | -$1.48B | $1.44B | -$1.23B | -$2.85B | -$2.67B | -$4.11B | -$1.41B | -$3.65B |
| Free cash flow | $3.49B | $1.48B | $961.0M | $4.25B | $1.91B | $980.0M | $4.40B | $3.31B |
| Capital expenditures | $513.0M | $712.0M | $642.0M | $436.0M | $369.0M | $411.0M | $371.0M | $257.0M |
| Depreciation & amortization | $1.11B | $1.12B | $1.13B | $1.31B | $1.34B | $1.39B | $1.40B | $1.40B |
| Share-based compensation | $165.0M | $75.0M | $125.0M | $127.0M | $157.0M | $85.0M | $134.0M | $136.0M |
| Deferred income taxes | — | — | -$700.0M | — | — | — | -$1.24B | — |
| Change in accounts receivable | $1.09B | -$413.0M | $1.07B | -$222.0M | $515.0M | $1.31B | -$473.0M | $342.0M |
| Change in inventory | $31.0M | -$18.0M | -$119.0M | -$240.0M | -$239.0M | -$288.0M | -$323.0M | -$681.0M |
| Change in accounts payable | -$70.0M | $571.0M | -$484.0M | -$174.0M | $589.0M | $497.0M | -$232.0M | -$122.0M |
| Purchases of investments | — | — | — | — | — | — | $0 | — |
| Sales/maturities of investments | — | — | $0 | — | — | — | $0 | $0 |
| Other investing activities | $56.0M | $4.0M | -$2.0M | -$22.0M | $20.0M | $36.0M | $31.0M | -$47.0M |
| Share repurchases | — | — | $0 | — | — | — | $200.0M | — |
| Debt issued | $0 | $3.96B | $0 | — | $0 | $0 | $0 | $0 |
| Debt repaid | $0 | $833.0M | $1.50B | $1.50B | $1.00B | $2.50B | $3.60B | $2.20B |
| Tax withholding on stock comp | — | — | — | — | — | — | — | — |
| Other financing activities | -$120.0M | -$104.0M | $57.0M | $10.0M | -$92.0M | -$27.0M | -$2.0M | $8.0M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $36.75B | $33.42B | $28.19B | $26.32B | $25.98B |
| Operating income | $9.08B | $7.26B | $7.90B | $9.57B | $7.64B |
| Net income | $7.71B | $4.09B | $6.72B | $6.55B | $5.89B |
| EPS (diluted) | $14.23 | $7.56 | $12.49 | $12.11 | $10.28 |
| EPS (basic) | $14.33 | $7.62 | $12.56 | $12.18 | $10.34 |
| Operating margin | $25 | $22 | $28 | $36 | $29 |
| Net margin | $21 | $12 | $24 | $25 | $23 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $90.59B | $91.84B | $97.15B | $65.12B | $61.16B |
| Stockholders' equity | $8.66B | $5.88B | $6.23B | $3.66B | $6.70B |
| Total current assets | $29.06B | $29.03B | $30.33B | $22.19B | $19.39B |
| Total current liabilities | $25.49B | $23.10B | $18.39B | $15.69B | $12.18B |
| Cash & equivalents | $9.13B | $11.97B | $10.94B | $7.63B | $7.99B |
| Accounts receivable | $9.57B | $6.78B | $7.27B | $5.56B | $4.89B |
| Inventory | $6.22B | $7.00B | $9.52B | $4.93B | $4.09B |
| Other current assets | $4.13B | $3.28B | $2.60B | $2.39B | $2.37B |
| Property, plant & equipment | $7.91B | $6.54B | $5.94B | $5.43B | $5.18B |
| Goodwill | $18.68B | $18.64B | $18.63B | $15.53B | $14.89B |
| Intangible assets | $22.28B | $27.70B | $32.64B | $16.08B | $15.18B |
| Other non-current assets | $12.66B | $9.93B | $9.61B | $5.90B | $6.52B |
| Accounts payable | $2.37B | $1.91B | $1.59B | $1.57B | $1.37B |
| Accrued liabilities | $18.52B | $17.64B | $15.36B | $12.52B | $10.73B |
| Short-term debt | $4.60B | $3.55B | $1.44B | $1.59B | $87.0M |
| Long-term debt | $50.01B | $56.55B | $63.17B | $37.35B | $33.22B |
| Other non-current liabilities | $2.38B | $2.35B | $2.33B | $2.65B | $2.46B |
| Common stock & paid-in capital | $34.02B | $33.53B | $33.07B | $32.51B | $32.10B |
| Retained earnings | -$25.11B | -$27.59B | -$26.55B | -$28.62B | -$24.60B |
| Accumulated other comprehensive income (loss) | -$258.0M | -$66.0M | -$289.0M | -$231.0M | -$796.0M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $9.96B | $11.49B | $8.47B | $9.72B | $9.26B |
| Investing cash flow | -$1.94B | -$1.05B | -$26.20B | -$6.04B | $733.0M |
| Financing cash flow | -$10.86B | -$9.41B | $21.05B | -$4.04B | -$8.27B |
| Free cash flow | $8.10B | $10.39B | $7.36B | $8.79B | $8.38B |
| Capital expenditures | $1.86B | $1.10B | $1.11B | $936.0M | $880.0M |
| Depreciation & amortization | $5.17B | $5.59B | $4.07B | $3.42B | $3.40B |
| Share-based compensation | $494.0M | $530.0M | $431.0M | $401.0M | $341.0M |
| Deferred income taxes | -$700.0M | -$1.24B | -$1.22B | -$1.27B | -$434.0M |
| Change in accounts receivable | $2.68B | -$441.0M | $1.01B | $746.0M | $429.0M |
| Change in inventory | -$886.0M | -$2.53B | -$491.0M | $742.0M | $165.0M |
| Change in accounts payable | $428.0M | $312.0M | -$402.0M | $154.0M | -$69.0M |
| Purchases of investments | — | $0 | $1.0M | $2.59B | $8.90B |
| Sales/maturities of investments | $0 | $0 | $1.12B | $98.0M | $4.40B |
| Other investing activities | $32.0M | -$50.0M | -$224.0M | -$100.0M | $192.0M |
| Share repurchases | $0 | $200.0M | $0 | $6.36B | $4.97B |
| Debt issued | $0 | $0 | $27.78B | $6.92B | $4.95B |
| Debt repaid | $5.00B | $3.60B | $1.45B | $0 | $4.15B |
| Tax withholding on stock comp | — | — | — | — | — |
| Other financing activities | -$52.0M | -$124.0M | -$72.0M | -$103.0M | -$78.0M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding AMGN as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 31 filers
Held by These Filers60.5%
Shares Outstanding540,000,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 49,362,016 | $17.87B | 9.14% | +4.8% | 2026-08-07 |
| VANGUARD CAPITAL MANAGEMENT LLC | 35,250,101 | $12.76B | 6.53% | +0.7% | 2026-06-30 |
| State Street Corp | 30,560,537 | $11.07B | 5.66% | +0.0% | 2026-08-07 |
| Capital World Investors | 29,075,329 | $10.53B | 5.38% | -0.7% | 2026-08-07 |
| Invesco Ltd. | 16,320,446 | $5.91B | 3.02% | +257.0% | 2026-08-13 |
| GEODE CAPITAL MANAGEMENT, LLC | 15,696,068 | $5.67B | 2.91% | +1.7% | 2026-08-12 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 15,034,038 | $5.44B | 2.78% | +17.7% | 2026-08-14 |
| Sixth Street Partners Management Company, L.P. | 15,034,038 | $5.44B | 2.78% | +0.0% | 2026-08-13 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 14,853,366 | $5.38B | 2.75% | +1.6% | 2026-06-30 |
| Morgan Stanley | 13,653,692 | $4.94B | 2.53% | -13.8% | 2026-08-11 |
| Wells Fargo & Company/Mn | 7,235,462 | $2.62B | 1.34% | +2.1% | 2026-08-14 |
| PRIMECAP MANAGEMENT CO/CA/ | 6,756,962 | $2.45B | 1.25% | -23.9% | 2026-08-14 |
| Capital Research Global Investors | 6,272,625 | $2.27B | 1.16% | -9.8% | 2026-08-07 |
| Northern Trust Corp | 6,200,994 | $2.25B | 1.15% | -0.3% | 2026-08-12 |
| NORGES BANK | 5,625,584 | $2.04B | 1.04% | +0.0% | 2026-08-12 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 5,390,910 | $1.95B | 1.00% | +12.7% | 2026-08-13 |
| Bank Of America Corp /De/ | 5,058,830 | $1.83B | 0.94% | -1.2% | 2026-08-14 |
| Royal Bank Of Canada | 4,328,785 | $1.57B | 0.80% | -3.2% | 2026-08-13 |
| Goldman Sachs Group Inc | 4,130,732 | $1.50B | 0.76% | -2.1% | 2026-08-14 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,956,992 | $1.4M | 0.73% | +111.9% | 2026-08-14 |
| Amundi | 3,890,189 | $1.41B | 0.72% | +15.2% | 2026-08-11 |
| Legal & General Group Plc | 3,816,942 | $1.38B | 0.71% | -1.4% | 2026-08-14 |
| Bank of New York Mellon Corp | 3,695,586 | $1.34B | 0.68% | -2.6% | 2026-08-06 |
| Jpmorgan Chase & Co | 3,588,484 | $1.29B | 0.66% | -50.7% | 2026-08-12 |
| FMR LLC | 3,491,822 | $1.26B | 0.65% | -7.5% | 2026-08-13 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-05-07 to 2026-08-13
Recent transactions
- Insiders have net sold 10,112 shares over the last 182 days, across 0 purchases and 6 sales.
- Most recent: Khosla Rachna (SVP, Business Development) — Option exercise of 1,252 shares on 2026-08-13.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)10,112 sh(6 txns)
Net Shares-10,112
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Khosla Rachna | SVP, Business Development | Option exercise | 2026-08-13 | 1,252 |
| Busch Matthew C. | VP, Finance & CAO | Grant / award | 2026-08-07 | 730 |
| ISHRAK OMAR | Director | Grant / award | 2026-08-07 | 85 |
| HOLLEY CHARLES M | Director | Grant / award | 2026-08-07 | 103 |
| Drake Michael V | Director | Grant / award | 2026-08-07 | 64 |
| Miller Derek | SVP, Human Resources | Option exercise | 2026-08-06 | 2,069 |
| Grygiel Nancy A. | SVP & CCO | Option exercise | 2026-08-06 | 1,970 |
| MILES AMY E | Director | Grant / award | 2026-05-19 | 665 |
| Kullman Ellen Jamison | Director | Grant / award | 2026-05-19 | 665 |
| Klotman Mary E. | Director | Grant / award | 2026-05-19 | 665 |
| Jacks Tyler | Director | Grant / award | 2026-05-19 | 665 |
| Garland Greg C. | Director | Grant / award | 2026-05-19 | 665 |
| ECKERT ROBERT | Director | Grant / award | 2026-05-19 | 665 |
| Druker Brian | Director | Grant / award | 2026-05-19 | 665 |
| Austin Wanda M | Director | Grant / award | 2026-05-19 | 665 |
| Santos Esteban | EVP, Operations | Tax withholding | 2026-05-07 | 522 |
| REESE DAVID M | EVP & Chief Technology Officer | Tax withholding | 2026-05-07 | 556 |
| Griffith Peter H. | EVP & CFO | Tax withholding | 2026-05-07 | 556 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-13 | Khosla Rachna | SVP, Business Development | Option exercise | 1,252 | $162.60 |
| 2026-08-13 | Khosla Rachna | SVP, Business Development | Open market sale | 1,252 | $416.43 |
| 2026-08-11 | Khosla Rachna | SVP, Business Development | Open market sale | 2,000 | $412.57 |
| 2026-08-07 | Busch Matthew C. | VP, Finance & CAO | Grant / award | 730 | $0.00 |
| 2026-08-07 | ISHRAK OMAR | Director | Grant / award | 85 | $0.00 |
| 2026-08-07 | HOLLEY CHARLES M | Director | Grant / award | 103 | $0.00 |
| 2026-08-07 | Drake Michael V | Director | Grant / award | 64 | $0.00 |
| 2026-08-06 | Miller Derek | SVP, Human Resources | Option exercise | 2,069 | $162.60 |
| 2026-08-06 | Miller Derek | SVP, Human Resources | Open market sale | 2,069 | $402.54 |
| 2026-08-06 | Miller Derek | SVP, Human Resources | Option exercise | 1,821 | $177.46 |
| 2026-08-06 | Miller Derek | SVP, Human Resources | Open market sale | 1,821 | $402.54 |
| 2026-08-06 | Grygiel Nancy A. | SVP & CCO | Option exercise | 1,970 | $177.46 |
| 2026-08-06 | Grygiel Nancy A. | SVP & CCO | Open market sale | 1,970 | $402.16 |
| 2026-08-06 | Grygiel Nancy A. | SVP & CCO | Option exercise | 1,000 | $177.31 |
| 2026-08-06 | Grygiel Nancy A. | SVP & CCO | Open market sale | 1,000 | $402.16 |
| 2026-05-19 | MILES AMY E | Director | Grant / award | 665 | $0.00 |
| 2026-05-19 | Kullman Ellen Jamison | Director | Grant / award | 665 | $0.00 |
| 2026-05-19 | Klotman Mary E. | Director | Grant / award | 665 | $0.00 |
| 2026-05-19 | Jacks Tyler | Director | Grant / award | 665 | $0.00 |
| 2026-05-19 | ISHRAK OMAR | Director | Grant / award | 665 | $0.00 |
| 2026-05-19 | HOLLEY CHARLES M | Director | Grant / award | 665 | $0.00 |
| 2026-05-19 | Garland Greg C. | Director | Grant / award | 665 | $0.00 |
| 2026-05-19 | ECKERT ROBERT | Director | Grant / award | 665 | $0.00 |
| 2026-05-19 | Druker Brian | Director | Grant / award | 665 | $0.00 |
| 2026-05-19 | Drake Michael V | Director | Grant / award | 665 | $0.00 |
| 2026-05-19 | Austin Wanda M | Director | Grant / award | 665 | $0.00 |
| 2026-05-07 | Busch Matthew C. | VP, Finance & CAO | Tax withholding | 41 | $331.11 |
| 2026-05-07 | Santos Esteban | EVP, Operations | Tax withholding | 522 | $331.11 |
| 2026-05-07 | REESE DAVID M | EVP & Chief Technology Officer | Tax withholding | 556 | $331.11 |
| 2026-05-07 | Miller Derek | SVP, Human Resources | Tax withholding | 151 | $331.11 |
| 2026-05-07 | Khosla Rachna | SVP, Business Development | Tax withholding | 93 | $331.11 |
| 2026-05-07 | Grygiel Nancy A. | SVP & CCO | Tax withholding | 88 | $331.11 |
| 2026-05-07 | Griffith Peter H. | EVP & CFO | Tax withholding | 556 | $331.11 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-09-03 12:39 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-13 | 4 | 2026-08-11 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-07 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-07 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-07 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-07 | View on SEC.gov → |
| 2026-08-07 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-08-07 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-04 | 8-K | 2026-08-04 | View on SEC.gov → |
| 2026-07-31 | 8-K | 2026-07-29 | View on SEC.gov → |
| 2026-05-21 | 4 | 2026-05-19 | View on SEC.gov → |
| 2026-05-21 | 4 | 2026-05-19 | View on SEC.gov → |
Recent news
Headlines about AMGN (Amgen Inc.). Links open the publisher — we don’t host full articles.
-
Dogs Of The Dow: No Buys And Few Worth Watching
SeekingAlpha · 2026-09-03 -
Is Amgen (AMGN) Reasonable Or Rich As Cash Flow Improves?
Yahoo · 2026-09-02 -
TEZSPIRE’s Positive EoE Phase 3 Results Could Be A Game Changer For Amgen (AMGN)
Yahoo · 2026-09-02 -
AMGEN TO PRESENT AT THE 2026 WELLS FARGO HEALTHCARE CONFERENCE
Yahoo · 2026-09-02 -
Amgen Stock Signals Its Confidence. The Market Agrees.
Yahoo · 2026-09-02 -
Which dow jones stocks are moving on Wednesday?
ChartMill · 2026-09-02 -
Rare-Disease Drug Tavneos Faces UK Withdrawal
Yahoo · 2026-09-02 -
J&J Faces Multiple Headwinds: Can the Healthcare Giant Sustain Growth?
Yahoo · 2026-09-02
No headlines in this category right now — try “All”.